Agency Information Collection Activities: Proposed Collection; Comment Request, 18426-18427 [2015-07727]
Download as PDF
<![CDATA[
18426
Federal Register / Vol. 80, No. 65 / Monday, April 6, 2015 / Notices
their child and community. Policies that
do not do this should be strengthened.
4.1.1 Increased efforts should be
made to educate the public and state
legislatures on the safety and value of
vaccines, the importance of
recommended vaccinations and the
ACIP schedule, and the risks posed by
low or under-vaccination in
communities and schools.
4.2 NVAC recommends information
on vaccination rates, vaccination
exemptions, and other preventative
health measures (e.g., whether a school
has a school nurse, etc.) for an
educational institution be made
available to parents.
4.2.1 Encourage educational
institutions and childcare facilities to
report vaccination rates publicly (e.g.,
via a school health grade or report).
4.3 NVAC recommends ‘‘on-time
vaccination’’ should be included as a
Quality Measure for all health plans,
public and private, as a first line
indicator of vaccine confidence. NVAC
acknowledges that other issues, such as
access, can also effect on time
vaccination.
Final Recommendation
5.1 The NVAC recommends that the
National Vaccine Program Office
(NVPO) should work with federal and
non-federal partners to develop an
implementation plan to address vaccine
confidence, including metrics, and
report back to NVAC on progress,
annually.
tkelley on DSK4VPTVN1PROD with NOTICES
II. Request for Comment
NVPO, on behalf of the NVAC
Vaccine Confidence Working Group,
requests input on the draft report and
draft recommendations. Please limit
your comments to three (3) pages.
III. Potential Responders
HHS invites input from a broad range
of stakeholders including individuals
and organizations that have interests in
immunization efforts and the role of
HHS in advancing those efforts.
Examples of potential responders
include, but are not limited to, the
following:
—General public;
—advocacy groups, non-profit
organizations, and public interest
organizations;
—academics, professional societies, and
healthcare organizations;
—public health officials and
immunization program managers;
—pediatric provider groups including
all physician and non-physician
providers that administer healthcare
services to children, including
pharmacists; and
VerDate Sep<11>2014
18:14 Apr 03, 2015
Jkt 235001
—representatives from the private
sector, including those from health
insurance organizations.
When responding, please self-identify
with any of the above or other categories
(include all that apply) and your name.
Anonymous submissions will not be
considered. Written submissions should
not exceed three to five (3–5) pages.
Please do not send proprietary,
commercial, financial, business,
confidential, trade secret, or personal
information.
Dated: March 31, 2015.
Bruce Gellin,
Deputy Assistant Secretary for Health,
Director, National Vaccine Program Office,
Executive Secretary, National Vaccine
Advisory Committee.
[FR Doc. 2015–07778 Filed 4–3–15; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Proposed Project: Notification of Intent
To Use Schedule III, IV, or V Opioid
Drugs for the Maintenance and
Detoxification Treatment of Opiate
Addiction Under 21 U.S.C. 823(g)(2)
(OMB No. 0930–0234)—Extension
The Drug Addiction Treatment Act of
2000 (‘‘DATA,’’ Pub. L. 106–310)
amended the Controlled Substances Act
(21 U.S.C. 823(g)(2)) to permit
practitioners (physicians) to seek and
obtain waivers to prescribe certain
approved narcotic treatment drugs for
the treatment of opiate addiction. The
legislation sets eligibility requirements
and certification requirements as well as
an interagency notification review
process for physicians who seek
waivers. The legislation was amended
in 2005 to eliminate the patient limit for
physicians in group practices, and in
2006, to permit certain physicians to
treat up to 100 patients.
To implement these provisions,
SAMHSA developed a notification form
(SMA–167) that facilitates the
submission and review of notifications.
The form provides the information
necessary to determine whether
practitioners (i.e., independent
physicians) meet the qualifications for
waivers set forth under the new law.
Use of this form will enable physicians
to know they have provided all
information needed to determine
whether practitioners are eligible for a
waiver.
However, there is no prohibition on
use of other means to provide requisite
information. The Secretary will convey
notification information and
determinations to the Drug Enforcement
Administration (DEA), which will
assign an identification number to
qualifying practitioners; this number
will be included in the practitioner’s
registration under 21 U.S.C. 823(f).
Practitioners may use the form for
three types of notification: (a) New, (b)
immediate, and (c) to notify of their
intent to treat up to 100 patients. Under
‘‘new’’ notifications, practitioners may
make their initial waiver requests to
SAMHSA. ‘‘Immediate’’ notifications
inform SAMHSA and the Attorney
General of a practitioner’s intent to
prescribe immediately to facilitate the
treatment of an individual (one) patient
under 21 U.S.C. 823(g)(2)(E)(ii). Finally,
the form may be used by physicians
with waivers to certify their need and
intent to treat up to 100 patients.
The form collects data on the
following items: Practitioner name; state
medical license number and DEA
registration number; address of primary
location, telephone and fax numbers;
email address; name and address of
E:\FR\FM\06APN1.SGM
06APN1
18427
Federal Register / Vol. 80, No. 65 / Monday, April 6, 2015 / Notices
group practice; group practice employer
identification number; names and DEA
registration numbers of group
practitioners; purpose of notification
new, immediate, or renewal;
certification of qualifying criteria for
treatment and management of opiate
dependent patients; certification of
capacity to refer patients for appropriate
counseling and other appropriate
ancillary services; certification of
maximum patient load, certification to
use only those drug products that meet
the criteria in the law. The form also
notifies practitioners of Privacy Act
considerations, and permits
practitioners to expressly consent to
disclose limited information to the
SAMHSA Buprenorphine Physician
Locator.
Since July 2002, SAMHSA has
received over 25,000 notifications and
has certified almost 27,000 physicians.
Fifty-none percent of the notifications
were submitted by mail or by facsimile,
with approximately forty-one percent
submitted through the Web based online
Number of
respondents
Purpose of submission
system. Approximately 60 percent of the
certified physicians have consented to
disclosure on the SAMHSA
Buprenorphine Physician Locator.
Respondents may submit the form
electronically, through a dedicated Web
page that SAMHSA will establish for the
purpose, as well as via U.S. mail.
There are no changes to the forms and
burden hours.
The following table summarizes the
estimated annual burden for the use of
this form.
Responses
per
respondent
Burden per
response
(hour)
Total burden
(hours)
Initial Application for Waiver ............................................................................
Notification to Prescribe Immediately ..............................................................
Notice to Treat up to 100 patients ...................................................................
1,500
50
500
1
1
1
.083
.083
.040
125
4
20
Total ..........................................................................................................
2,050
........................
........................
149
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 2–1057, One Choke Cherry Road,
Rockville, MD 20857 or email her a
copy at summer.king@samhsa.hhs.gov.
Written comments should be received
by June 5, 2015.
Summer King,
Statistician.
[FR Doc. 2015–07727 Filed 4–3–15; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number CDC–2015–0008; NIOSH–
282]
International Labour Office (ILO)
Reference Radiographs
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Request for information and
comment.
AGENCY:
tkelley on DSK4VPTVN1PROD with NOTICES
Electronic or written comments
must be received by June 5, 2015.
DATES:
VerDate Sep<11>2014
18:14 Apr 03, 2015
Jkt 235001
You may submit comments,
identified by CDC–2015–0008 and
docket number NIOSH–282, by any of
the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: National Institute for
Occupational Safety and Health, NIOSH
Docket Office, 1090 Tusculum Avenue,
MS C–34, Cincinnati, OH 45226–1998.
ADDRESSES:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease and
Prevention is collaborating with the
Labour Inspection, Labour
Administration and Occupational Safety
and Health Branch of the International
Labour Office (ILO) in developing a set
of digital reference radiographs for the
ILO International Classification of
SUMMARY:
Radiographs of Pneumoconiosis (ILO
Classification). The current ILO
Classification depends on 22 standard
reference radiographs that are used to
formally identify and characterize
pneumoconiosis and related pulmonary
abnormalities arising from occupational
exposure. The original standards were
based on film radiography, but the
advent of digital radiography has led to
the need for reference standards based
on digitally-acquired images. NIOSH is
assisting the ILO in the process of
identifying such digital images.
For this purpose, NIOSH is requesting
trained users of the ILO Classification
(e.g., NIOSH B-Readers [1] and other
such experts) to submit comments
regarding any of the current standard
reference images that are felt to be
deficient and for which improvements
could be made. The current structure
and format of the ILO Classification is
to remain unchanged at the present
time. NIOSH is not soliciting comments
on the ILO Classification itself.
Comments received on the ILO
Classification will be considered
irrelevant to the purpose of this docket.
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
Instructions: All information received
in response to this notice must include
the agency name and docket number
(CDC–2015–0008; NIOSH–282). All
relevant comments received will be
posted without change to
www.regulations.gov, including any
personal information provided. All
electronic comments should be
formatted as Microsoft Word. For access
to the docket to read background
documents or comments received, go to
www.regulations.gov. All information
received in response to this notice will
also be available for public examination
and copying at the NIOSH Docket
Office, 1150 Tusculum Avenue, Room
155, Cincinnati, OH 45226.
FOR FURTHER INFORMATION CONTACT:
Michael Attfield, 1095 Willowdale
Road, Morgantown, WV 26505–2888,
telephone (304) 285–5737 (this is not a
toll free number).
SUPPLEMENTARY INFORMATION:
Table of Contents
• Background
• Information Needs
• References
Background: Chest radiographs (XRays) provide critical medical
information for the assessment of the
pneumoconioses and related disorders
in individuals, for example, those
caused by inhaling coal, silica, and
asbestos dusts [2]. Prior to 1950, the
information evident on a radiograph
could only be interpreted qualitatively.
However in 1950, the International
Labour Office (ILO) established a more
quantitative system whereby the various
parenchymal and pleural changes could
be formally recognized and categorized.
E:\FR\FM\06APN1.SGM
06APN1
]]>Agencies
[Federal Register Volume 80, Number 65 (Monday, April 6, 2015)]
[Notices]
[Pages 18426-18427]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-07727]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer on (240) 276-1243.
Comments are invited on: (a) Whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: Notification of Intent To Use Schedule III, IV, or V
Opioid Drugs for the Maintenance and Detoxification Treatment of Opiate
Addiction Under 21 U.S.C. 823(g)(2) (OMB No. 0930-0234)--Extension
The Drug Addiction Treatment Act of 2000 (``DATA,'' Pub. L. 106-
310) amended the Controlled Substances Act (21 U.S.C. 823(g)(2)) to
permit practitioners (physicians) to seek and obtain waivers to
prescribe certain approved narcotic treatment drugs for the treatment
of opiate addiction. The legislation sets eligibility requirements and
certification requirements as well as an interagency notification
review process for physicians who seek waivers. The legislation was
amended in 2005 to eliminate the patient limit for physicians in group
practices, and in 2006, to permit certain physicians to treat up to 100
patients.
To implement these provisions, SAMHSA developed a notification form
(SMA-167) that facilitates the submission and review of notifications.
The form provides the information necessary to determine whether
practitioners (i.e., independent physicians) meet the qualifications
for waivers set forth under the new law. Use of this form will enable
physicians to know they have provided all information needed to
determine whether practitioners are eligible for a waiver.
However, there is no prohibition on use of other means to provide
requisite information. The Secretary will convey notification
information and determinations to the Drug Enforcement Administration
(DEA), which will assign an identification number to qualifying
practitioners; this number will be included in the practitioner's
registration under 21 U.S.C. 823(f).
Practitioners may use the form for three types of notification: (a)
New, (b) immediate, and (c) to notify of their intent to treat up to
100 patients. Under ``new'' notifications, practitioners may make their
initial waiver requests to SAMHSA. ``Immediate'' notifications inform
SAMHSA and the Attorney General of a practitioner's intent to prescribe
immediately to facilitate the treatment of an individual (one) patient
under 21 U.S.C. 823(g)(2)(E)(ii). Finally, the form may be used by
physicians with waivers to certify their need and intent to treat up to
100 patients.
The form collects data on the following items: Practitioner name;
state medical license number and DEA registration number; address of
primary location, telephone and fax numbers; email address; name and
address of
[[Page 18427]]
group practice; group practice employer identification number; names
and DEA registration numbers of group practitioners; purpose of
notification new, immediate, or renewal; certification of qualifying
criteria for treatment and management of opiate dependent patients;
certification of capacity to refer patients for appropriate counseling
and other appropriate ancillary services; certification of maximum
patient load, certification to use only those drug products that meet
the criteria in the law. The form also notifies practitioners of
Privacy Act considerations, and permits practitioners to expressly
consent to disclose limited information to the SAMHSA Buprenorphine
Physician Locator.
Since July 2002, SAMHSA has received over 25,000 notifications and
has certified almost 27,000 physicians. Fifty-none percent of the
notifications were submitted by mail or by facsimile, with
approximately forty-one percent submitted through the Web based online
system. Approximately 60 percent of the certified physicians have
consented to disclosure on the SAMHSA Buprenorphine Physician Locator.
Respondents may submit the form electronically, through a dedicated
Web page that SAMHSA will establish for the purpose, as well as via
U.S. mail.
There are no changes to the forms and burden hours.
The following table summarizes the estimated annual burden for the
use of this form.
----------------------------------------------------------------------------------------------------------------
Burden per
Purpose of submission Number of Responses per response Total burden
respondents respondent (hour) (hours)
----------------------------------------------------------------------------------------------------------------
Initial Application for Waiver.................. 1,500 1 .083 125
Notification to Prescribe Immediately........... 50 1 .083 4
Notice to Treat up to 100 patients.............. 500 1 .040 20
---------------------------------------------------------------
Total....................................... 2,050 .............. .............. 149
----------------------------------------------------------------------------------------------------------------
Send comments to Summer King, SAMHSA Reports Clearance Officer,
Room 2-1057, One Choke Cherry Road, Rockville, MD 20857 or email her a
copy at summer.king@samhsa.hhs.gov. Written comments should be received
by June 5, 2015.
Summer King,
Statistician.
[FR Doc. 2015-07727 Filed 4-3-15; 8:45 am]
BILLING CODE 4162-20-P
